Literature DB >> 19035844

Jay and Jeanie Schottenstein prize in cardiovascular science: predicting cardiovascular illnesses for the 21(st) century, and the unpredictable...

Pascal J Goldschmidt-Clermont.   

Abstract

Changes in our society such as the increasing cost of retirement and age redistribution toward a larger elderly population will require humans to remain highly functional until an advanced age. As a consequence, chronic illnesses that are primarily responsible for reducing functionality and life expectancy will require improved prevention and therapeutic strategies. In a global way, cardiovascular disease and cancer represent the most challenging disorders to maintaining the functional integrity of our fellow humans. A new theory has been derived from recent progress in our understanding of atherosclerosis as a key mechanism for cardiovascular disease and of cancer. Instructively, this theory provides a bridge at the stem cell level, linking most chronic disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19035844      PMCID: PMC2933575          DOI: 10.1089/ars.2008.2381

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  24 in total

1.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

Authors:  Jonathan M Hill; Gloria Zalos; Julian P J Halcox; William H Schenke; Myron A Waclawiw; Arshed A Quyyumi; Toren Finkel
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

Review 2.  On the memory of a chronic illness.

Authors:  Pascal J Goldschmidt-Clermont; Eric D Peterson
Journal:  Sci Aging Knowledge Environ       Date:  2003-11-12

3.  Molecular evidence for arterial repair in atherosclerosis.

Authors:  Ravi Karra; Sreekanth Vemullapalli; Chunming Dong; Edward E Herderick; Xiaohua Song; Kathy Slosek; Joseph R Nevins; Mike West; Pascal J Goldschmidt-Clermont; David Seo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

4.  Circulating endothelial progenitor cells and cardiovascular outcomes.

Authors:  Nikos Werner; Sonja Kosiol; Tobias Schiegl; Patrick Ahlers; Katrin Walenta; Andreas Link; Michael Böhm; Georg Nickenig
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

5.  Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts.

Authors:  K Irani; Y Xia; J L Zweier; S J Sollott; C J Der; E R Fearon; M Sundaresan; T Finkel; P J Goldschmidt-Clermont
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

6.  HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.

Authors:  S Dimmeler; A Aicher; M Vasa; C Mildner-Rihm; K Adler; M Tiemann; H Rütten; S Fichtlscherer; H Martin; A M Zeiher
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 7.  Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?

Authors:  Stefanie Dimmeler; Andreas M Zeiher
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

8.  Aging, progenitor cell exhaustion, and atherosclerosis.

Authors:  Frederick M Rauscher; Pascal J Goldschmidt-Clermont; Bryce H Davis; Tao Wang; David Gregg; Priya Ramaswami; Anne M Pippen; Brian H Annex; Chunming Dong; Doris A Taylor
Journal:  Circulation       Date:  2003-07-14       Impact factor: 29.690

Review 9.  Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis.

Authors:  Pascal J Goldschmidt-Clermont
Journal:  Am Heart J       Date:  2003-10       Impact factor: 4.749

10.  Genetically elevated C-reactive protein and ischemic vascular disease.

Authors:  Jeppe Zacho; Anne Tybjaerg-Hansen; Jan Skov Jensen; Peer Grande; Henrik Sillesen; Børge G Nordestgaard
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.